Companies Attending the Summit

6th Cell Therapy Analytical Development Summit 2024

Develop Robust Analytical Methods & Tools in a Phase-Appropriate & Cost-Efficient Manner, to Improve Cell Characterization, Expedite Product Release & Gain Regulatory Approval

EVENT GUIDE

PARTNER WITH US

Welcome to the 6th Cell Therapy Analytical Development Summit

Demonstrating your cell therapy’s superior safety and efficacy is vital for standing out in a competitive market and attracting investment. Integrating cutting-edge technologies and robust analytical methods is key to showcasing your product's strengths and securing regulatory approval.

Join the 6th Cell Therapy Analytical Development Summit to advance your analytics, accelerate through IND and clinical trials, and achieve regulatory success.

Explore three focused tracks on immunophenotype, cell-based, and molecular assays. Collaborate with industry leaders like Bristol Myers Squibb, Kite Pharma, and Takeda, and gain actionable insights to propel your pipeline forward.

Engage with experts to overcome challenges in potency, product characterization, method validation, release, and scale-up.

Together, let’s elevate the development of potent, safe, and effective cell therapies.

Download the Event Guide, 6th Cell Therapy Analytical Development Summit 2024

Our Expert Speaker Faculty:

Alexandre Ambrogelly

Executive Director - Analytical Operations

Kite Pharma Inc

Benjamin Espen

Principal Quality Engineer

Avobis Bio

Fan Yang

Vice President of Cell Therapy

Independent Expert

Haixia Wang

Director

Arsenal Bio

Shibani Mitra-Kaushik

Head Of Analytical Development & Cell Therapies

Takeda Pharmaceutical

Stephen Krause, Cell Therapy Analytical Development

Stephan Krause

Executive Director AS&T

Bristol Myers Squibb

VIEW FULL SPEAKER FACULTY

Our Partners:

Lead

Miltenyi Biotec - Cell Therapy Analytical Development

Expertise

Agilent - Cell Therapy Analytical Development

ThermoFisher Scientific - Cell Therapy Analytical Development

Program

Accelix - Cell Therapy Analytical Development

Biomerieux - Cell Therapy Analytical Development

LumaCyte - Cell Therapy Analytical Development

Innovation

Axion - Cell Therapy Analytical Development

comprehensive cell solutions, Cell Therapy Analytical Development

Mission Bio - Cell Therapy Analytical Development

Exhibition

"This summit highlights the need for continued conversations on analytical assay design for cell therapies. In 2024, I look forward to discussing major changes ushered into CGT development via the novel platform technology designation and potency assurance.”
Manager, Science & Industry Affairs, Alliance for Regenerative Medicine (2024 Speaker)

"With constantly evolving therapies and their regulations, it is important to have a space like this for the stakeholders to come together and share their knowledge and experiences.”
Senior Scientist, Process Development Drug Substance, Satellite Bio (2024 Speaker)

"I have been a regular attendee at this conference and it's always been a spot to meet new cell therapy SMEs and reconnect with some others.”
Head of Analytical Development, Takeda (2024 Speaker)

"The 6th Cell Therapy Analytical Development Summit is a pivotal event for advancing the field of cell therapy. It provides an unparalleled platform for sharing cutting-edge research, fostering collaborations, and addressing the latest challenges in analytical development. I am eagerly looking forward to the 2024 meeting in Boston to engage with industry leaders and contribute to the discussions that will shape the future of cell therapy.”
Director, Quality Assurance & Regulatory Affairs, University of Minnesota (2024 Speaker)

"I enjoyed the well-organized conference and streamlined tracks of different focus. I learned what the key questions are that all are interested in and need to be addressed, which will guide us to better develop cell therapy drugs.”
Principal Scientist, Merck & Co. (Past Attendee)

"Cell therapy processes and assays are very complex. We are looking forward to hearing about new technologies and innovations in cell therapy development. We also would like to learn the regulatory perspective towards release assays.”
Vice President, Cell Therapy, Aisaer/IxCell Biotechnology (2024 Speaker)